EGG DONOR & SURROGATE SOLUTIONS, LLC – Trademark Portfolio
Entity Type: 16
EGG DONOR & SURROGATE SOLUTIONS, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 5 filings in this category. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include SS SURROGATE SOLUTIONS, EGG DONOR & SURROGATE SOLUTIONS, and BE THE SOLUTION. CREATE A HAPPY FAMILY.. The owner is based in FRISCO, TX.
6136 FRISCO SQUARE BLVD. SUITE 400
FRISCO, TX 75034
Showing of trademarks Trademarks
Trademark Classifications
EGG DONOR & SURROGATE SOLUTIONS, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does EGG DONOR & SURROGATE SOLUTIONS, LLC have?
EGG DONOR & SURROGATE SOLUTIONS, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 1 cancelled.
What trademark classes does EGG DONOR & SURROGATE SOLUTIONS, LLC file in?
EGG DONOR & SURROGATE SOLUTIONS, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are EGG DONOR & SURROGATE SOLUTIONS, LLC's most well-known trademarks?
EGG DONOR & SURROGATE SOLUTIONS, LLC's registered trademark portfolio includes well-known marks such as SS SURROGATE SOLUTIONS, EGG DONOR & SURROGATE SOLUTIONS, and BE THE SOLUTION. CREATE A HAPPY FAMILY.. These are among 3 currently registered trademarks in the portfolio.
What is EGG DONOR & SURROGATE SOLUTIONS, LLC's trademark registration success rate?
EGG DONOR & SURROGATE SOLUTIONS, LLC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.